Mr. Cedrone’s recent matters include the following:
- Co-authored successful merits briefs for the petitioner in the U.S. Supreme Court in Banister v. Davis, 140 S. Ct. 1698 (2020). In a 7–2 decision, the Court held that a timely filed Rule 59(e) motion to alter or amend the judgment in a federal habeas case is not an improper “second or successive” habeas petition.
- Briefed and argued a successful immigration appeal in the U.S. Court of Appeals for the Second Circuit. See Mendez v. Barr, 960 F.3d 80 (2020). The court reversed the Board of Immigration Appeals’ determination that misprision of a felony in violation of 18 U.S.C. § 4 is categorically a crime involving moral turpitude.
- Co-authored briefs successfully defending an antitrust class-action settlement in an appeal raising an issue of first impression regarding the authority of insurance claims administrators to opt customers out of class action settlements. See In re Aggrenox Antitrust Litigation, 2020 WL 2146901 (2d Cir. 2020).
- Co-authored briefs in the D.C. Circuit securing dismissal of a challenge to a shipping client’s eligibility to participate in the federal Maritime Security Program. See Matson Navigation Co. v. U.S. Department of Transportation, 895 F.3d 799 (2018).
- Represented Braeburn in a successful lawsuit against the U.S. Food and Drug Administration. Co-authored summary-judgment briefing persuading the district court to vacate an exclusivity determination that blocked Braeburn’s new drug product BRIXADI™, a treatment for moderate to severe opioid use disorder, from receiving final approval. See Braeburn Inc. v. FDA, 389 F. Supp. 3d 1 (D.D.C. 2019).